|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 41, Issue 3 187-192, Copyright © 1991 by American Cancer Society
"Laetrile" is used interchangeably with "amygdalin" to designate natural
substances, derived primarily from apricots and almonds, that can release
cyanide, which is lethal to living organisms. In the 1920s, Dr. Ernst T.
Krebs, Sr., formulated a theory that amygdalin could kill cancer cells. His
theory was inconsistent with biochemical facts and has since been modified
at least twice by his son, Ernst T. Krebs, Jr. Extensive work has been done
by cancer scientists to test the claim that Laetrile fights cancer. Many
animal experiments in the 1970s showed a complete lack of tumor killing by
Laetrile. Reviews of the medical records of patients whose cancers were
claimed to be reduced or cured after Laetrile treatment found insufficient
medical evidence to judge Laetrile's efficacy. Finally, in a clinical trial
in cancer patients reported in 1982, Laetrile neither caused shrinkage of
tumors, nor increased survival time, nor alleviated cancer symptoms, nor
enhanced well-being. Several reports in the medical literature document
instances in which Laetrile has caused serious, life-threatening toxicity
when taken in large doses in the manner prescribed by Laetrile advocates.
In light of the lack of efficacy of Laetrile and its demonstrated ability
to cause harm, Laetrile should not be used to treat cancer.
ARTICLES
Unproven methods of cancer management. Laetrile
This article has been cited by other articles:
![]() |
J. Bromley, B. G. Hughes, D. C. Leong, and N. A Buckley Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C Ann. Pharmacother., September 1, 2005; 39(9): 1566 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Cassileth and G. Deng Complementary and Alternative Therapies for Cancer Oncologist, February 1, 2004; 9(1): 80 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Cohen and D. M. Eisenberg Potential Physician Malpractice Liability Associated with Complementary and Integrative Medical Therapies Ann Intern Med, April 16, 2002; 136(8): 596 - 603. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |